ATE239781T1 - Immortalisierte menschliche prostata- epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs - Google Patents

Immortalisierte menschliche prostata- epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs

Info

Publication number
ATE239781T1
ATE239781T1 AT97904061T AT97904061T ATE239781T1 AT E239781 T1 ATE239781 T1 AT E239781T1 AT 97904061 T AT97904061 T AT 97904061T AT 97904061 T AT97904061 T AT 97904061T AT E239781 T1 ATE239781 T1 AT E239781T1
Authority
AT
Austria
Prior art keywords
cell lines
clones
therapy
study
epithelial cells
Prior art date
Application number
AT97904061T
Other languages
English (en)
Inventor
Suzanne L Topalian
W Marston Linehan
Robert K Bright
Cathy D Vocke
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE239781T1 publication Critical patent/ATE239781T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0683—Cells of the male genital tract, e.g. prostate, epididymis; Non-germinal cells from testis, e.g. Leydig cells, Sertoli cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT97904061T 1996-02-02 1997-01-30 Immortalisierte menschliche prostata- epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs ATE239781T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1104296P 1996-02-02 1996-02-02
PCT/US1997/001430 WO1997028255A1 (en) 1996-02-02 1997-01-30 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

Publications (1)

Publication Number Publication Date
ATE239781T1 true ATE239781T1 (de) 2003-05-15

Family

ID=21748614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97904061T ATE239781T1 (de) 1996-02-02 1997-01-30 Immortalisierte menschliche prostata- epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs

Country Status (8)

Country Link
US (1) US6982168B1 (de)
EP (1) EP0877798B1 (de)
JP (2) JP2000506379A (de)
AT (1) ATE239781T1 (de)
AU (1) AU755554B2 (de)
CA (1) CA2245099C (de)
DE (1) DE69721731T2 (de)
WO (1) WO1997028255A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827102D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
JP2003500366A (ja) * 1999-05-21 2003-01-07 オニバックス リミティド 新規ワクチン製剤２
GB9911823D0 (en) * 1999-05-21 1999-07-21 Onyvax Ltd New vaccine formulations
WO2000071156A2 (en) * 1999-05-21 2000-11-30 Onyvax Limited New vaccine formulations-3
DE60144515D1 (de) * 2000-04-01 2011-06-09 Onyvax Ltd Prostata zellinien und deren verwendung
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
GB2426523B (en) 2004-03-01 2008-10-22 Kitakyushu Foundation Human cell strains for protein production,provided by selecting strains with high intracellular protein and mutating with carcinogens
WO2008013918A2 (en) * 2006-07-26 2008-01-31 Myelin Repair Foundation, Inc. Cell cycle regulation and differentiation
US8715732B2 (en) * 2009-01-05 2014-05-06 Cornell University Nucleic acid hydrogel via rolling circle amplification
US20130219531A1 (en) * 2011-08-19 2013-08-22 Tuskegee University Immortalized human prostate cell lines
WO2018119295A1 (en) * 2016-12-22 2018-06-28 Ventana Medical Systems, Inc. Fully automated nucleic acid extraction method for tissue samples

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443954A (en) 1987-10-30 1995-08-22 The United States Of America As Represented By The Department Of Health And Human Services Immortalized non-tumorigenic human bronchial epithelial cell lines
US5026637A (en) 1989-02-28 1991-06-25 Herbert Soule Immortal human mammary epithelial cell lines
GB9105532D0 (en) 1991-03-15 1991-05-01 Imutran Ltd Antibody production
US5376542A (en) 1992-04-27 1994-12-27 Georgetown University Method for producing immortalized cell lines using human papilluma virus genes
US5462870A (en) 1993-04-23 1995-10-31 Wayne State University Human diploid salivary gland epithelial cell lines
US5824488A (en) 1994-04-28 1998-10-20 Board Of Trustees Operating Michigan State University Immortalized and malignant human prostatic cell lines
US5610043A (en) 1994-04-28 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus

Also Published As

Publication number Publication date
EP0877798A1 (de) 1998-11-18
JP2006122052A (ja) 2006-05-18
JP2000506379A (ja) 2000-05-30
DE69721731T2 (de) 2004-03-18
CA2245099C (en) 2007-01-09
CA2245099A1 (en) 1997-08-07
US6982168B1 (en) 2006-01-03
EP0877798B1 (de) 2003-05-07
AU7749398A (en) 2000-02-24
AU755554B2 (en) 2002-12-12
WO1997028255A1 (en) 1997-08-07
DE69721731D1 (de) 2003-06-12

Similar Documents

Publication Publication Date Title
ATE239781T1 (de) Immortalisierte menschliche prostata- epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs
DE69622871D1 (de) Tetralin-verbindungen mit multi-drugresistenz (mdr)-aktivitat
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
ATE286053T1 (de) Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
BR0206985A (pt) Anticorpos modificados e métodos de uso
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
EP1467757A4 (de) Verwendung von antikörpern gegen das muc18-antigen
ATE194660T1 (de) Veraendertes gen bei menschlichem colorektalem- krebs
HUP9801826A2 (hu) HER-2/neu-fehérje intracelluláris doménje, és alkalmazása malignitások megelőzésére és kezelésére
BR0015194A (pt) Uso de um inibidor de egfr-tirosina-quinase, e, métodos para redução da transformação de células epiteliais e para causar reversão substancial de tecido epitelial
BR0316296A (pt) Compostos lapacone e seus métodos de uso
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
ATE260639T1 (de) Sialylzucker und ihre derivaten enthaltende topische zubereitungen
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DE69734838D1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
TR200200278T2 (tr) Kalsilitik bileşimler
DE60039863D1 (de) Verwendung von zytokinen und mitogenen zur inhibierung von pathologischen immunantworten
BE902280A (fr) Nouvelles compositions cosmetiques renfermant des extraits lyses d'hafnia.
DE69033810D1 (de) Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper
ES8800725A1 (es) Un procedimiento para producir un anticuerpo monoclonal

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties